Neonatal exchange transfusion in a transitioning healthcare system: a 23-year national trends analysis from Serbia
Transfusion Clinique et Biologique · 2026-02 · 33 (1) · 25-29
DOI: 10.1016/j.tracli.2025.10.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion Clinique et Biologique, 2026-02. Verfasst von Ljiljana Zdelar Stojanović und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Gynecology and Obstetrics, University Clinical Center of Serbia, Belgrade, Serbia. Hauptthemen laut MEDLINE: Exchange Transfusion, Whole Blood, Hyperbilirubinemia, Neonatal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Neonatal hyperbilirubinemia remains a common neonatal condition. While Rh immunoprophylaxis and phototherapy have dramatically reduced exchange transfusion (ET) use in high-income countries, ET remains essential in selected cases, particularly in transitioning healthcare systems. Comprehensive data from Southeast Europe are limited. AIM: To evaluate 23-year trends in neonatal ET use, indications, and outcomes at a Serbian tertiary referral center. METHODS: This retrospective cohort study (2001-2023) included all neonates undergoing ET at the University Clinical Center of Serbia. Data were collected from medical, transfusion, and laboratory records. Primary outcome was ET rate trend; secondary outcomes included indications and complications. RESULTS: Among 145,702 deliveries, 243 ETs were performed in 206 neonates. ET rates declined significantly from 6.4 to 0 per 1000 deliveries (p < 0.001), mirroring trends observed in high-income countries. Hemolytic disease of the newborn accounted for 67 % of cases, primarily due to anti-D alloimmunization (65.9 %), a profile characteristic of settings with Rh prophylaxis gaps. Non-immune indications included anemia (36.7 %), infections (28.3 %), and other causes (35.0 %). Most procedures were double-volume ET (61.3 %). No ET-related mortality occurred; complications were transient. RhD-negative mothers showed high sensitization rates (82.1 %). CONCLUSION: The significant decline in ET rates in Serbia reflects successful perinatal care improvements, yet the persistent burden of anti-D alloimmunization underscores challenges shared with many transitioning health systems. Strengthening Rh immunoprophylaxis programs and expanding access to bilirubin monitoring are essential public health strategies to further reduce ET need in similar healthcare settings worldwide.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinic of Gynecology and Obstetrics, University Clinical Center of Serbia, Belgrade, Serbia.
- Transfusion Medicine Department, Emergency Center, University Clinical Centre of Serbia, Belgrade, Serbia.
- Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
- Department of Transfusiology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia; Blood Transfusion Institute of Vojvodina, Novi Sad, Serbia. Electronic address: jasmina.grujic@mf.uns.ac.rs.
Zitieren
APA
Stojanović, L. Z., Petrović, B., Dinić, R., Šljivančanin, D., Mitrović, M. P., Vojvodić, A., Nikolić, L., & Grujić, J. (2026). Neonatal exchange transfusion in a transitioning healthcare system: a 23-year national trends analysis from Serbia. Transfusion Clinique et Biologique, 33(1), 25-29. https://doi.org/10.1016/j.tracli.2025.10.005
Vancouver
Stojanović LZ, Petrović B, Dinić R, Šljivančanin D, Mitrović MP, Vojvodić A, et al. Neonatal exchange transfusion in a transitioning healthcare system: a 23-year national trends analysis from Serbia. Transfusion Clinique et Biologique. 2026;33(1):25-29. doi:10.1016/j.tracli.2025.10.005
BibTeX
@article{Stojanovi2026,
author = {Stojanović, Ljiljana Zdelar and Petrović, Bojana and Dinić, Radovan and Šljivančanin, Dragiša and Mitrović, Milena Perišić and Vojvodić, Anja and Nikolić, Ljubinka and Grujić, Jasmina},
title = {Neonatal exchange transfusion in a transitioning healthcare system: a 23-year national trends analysis from Serbia},
journal = {Transfusion Clinique et Biologique},
year = {2026},
volume = {33},
number = {1},
pages = {25--29},
doi = {10.1016/j.tracli.2025.10.005}
}
EUVIMED